Axonics Modulation Technologies, Inc. (AXNX)

Trade AXNX now with
11/5/2019 6:11:19 AM Axonics Says Prepared To Act Quickly And Defend Itself Aggressively Medtronic Patent Lawsuit
10/7/2019 6:05:16 AM Axonics Achieves Two Milestones That Expand Its Commercial Reach In France And Norway
10/3/2019 6:06:54 AM Axonics Presents Full One-Year Results From ARTISAN-SNM Pivotal Study At AUGS/IUGA Joint Scientific Meeting
10/2/2019 6:05:16 AM Axonics Modulation Tech Agrees To Supply Axonics R-SNM® System To Adult Pediatric Urology And Urogynecology
9/9/2019 6:12:25 AM Axonics Announces FDA Approval For Its Sacral Neuromodulation System
7/29/2019 6:02:47 AM Axonics Announces Publication Of ARTISAN Clinical Study Results In The Journal Of Urology
6/18/2019 6:03:46 AM Axonics Announces FDA Approves Use Of Full-Body MRI For Pivotal Study Patients
4/8/2019 6:04:20 AM Axonics Names Nancy Snyderman And Jane Kiernan To Board
3/4/2019 6:03:41 AM Axonics Adds Michael Carrel To Board
2/19/2019 6:07:30 AM Axonics Announces Positive Top-Line Clinical Data From Its ARTISAN-SNM Pivotal Study
2/12/2019 6:03:51 AM Axonics Submits Full Body MRI Data To FDA For Sacral Neuromodulation System
1/7/2019 12:05:19 AM Axonics Ready To Charge Up?
1/2/2019 9:04:16 AM Axonics Submits Interim Clinical Data To FDA For Its Sacral Neuromodulation System
12/11/2018 4:05:02 PM Axonics Modulation Technologies Q3 Loss/share $2.67 Vs. Loss $1.67 Year Ago